XML 36 R22.htm IDEA: XBRL DOCUMENT v3.25.3
Note 9 - Stock-based Compensation
12 Months Ended
Sep. 27, 2025
Notes to Financial Statements  
Share-Based Payment Arrangement [Text Block]

(9) Stock-Based Compensation

 

Under our equity incentive plan, employees and directors may be granted stock options, restricted stock, restricted stock units and performance awards. Effective February 11, 2025, the shareholders of the Company approved the 2025 Equity Incentive Plan of Insteel Industries Inc. (the “2025 Plan”), which authorizes the issuance of up to 800,000 shares of our common stock, plus any shares remaining available for grant under the 2015 Equity Incentive Plan of Insteel Industries Inc. (as amended, the “2015 Plan”) as of the effective date of the 2025 Plan and any shares subject to an award granted under the 2015 Plan which are forfeited, cancelled, terminated, lapsed or expired without the issuance of shares. The 2025 Plan, which expires on February 10, 2035, replaces the 2015 Plan, which expired on February 17, 2025. As of September 27, 2025, there were 905,000 shares of our common stock available for future grants under the 2025 Plan, which is our only active equity incentive plan.

 

Stock option awards. Under our equity incentive plan, employees and directors may be granted options to purchase shares of common stock at the fair market value on the date of the grant. Options granted under the plan generally vest over three years and expire ten years from the date of the grant. Compensation expense associated with stock options was $1.4 million in 2025, $1.4 million in 2024 and $1.0 million in 2023. As of September 27, 2025, there was $712,000 of unrecognized compensation cost related to unvested options which is expected to be recognized over a weighted average period of 2.20 years.

 

The fair value of each option award granted is estimated on the date of grant using a Monte Carlo valuation model. The weighted-average estimated fair values of stock options granted during 2025, 2024 and 2023 were $12.70, $13.01 and $13.27 per share, respectively, based on the following weighted-average assumptions:

 

   

Year Ended

 
   

September 27,

   

September 28,

   

September 30,

 
   

2025

   

2024

   

2023

 

Expected term (in years)

    4.62       4.20       4.35  

Risk-free interest rate

    4.29 %     4.12 %     4.27 %

Expected volatility

    39.32 %     44.83 %     49.61 %

Expected dividend yield

    0.38 %     0.36 %     0.40 %

 

The assumptions utilized in the Monte Carlo valuation model are evaluated and revised, as necessary, to reflect market conditions and actual historical experience. The expected term for options was based on the results of a Monte Carlo simulation model, using the model’s estimated fair value as an input to the Black-Scholes-Merton model, and then solving for the expected term. The risk-free interest rate for periods within the contractual life of the option was based on the U.S. Treasury yield curve in effect at the time of the grant. The expected volatility was derived using a term structure based on historical volatility and the volatility implied by exchange-traded options on our common stock. The dividend yield was calculated based on our annual dividend as of the option grant date.

 

The following table summarizes stock option activity:

 

                   

Contractual

   

Aggregate

 
   

Options

   

Weighted

   

Term - Weighted

   

Intrinsic

 
   

Outstanding

   

Average

   

Average

   

Value

 
   

(in thousands)

   

Exercise Price

   

(in years)

   

(in thousands)

 

Outstanding at October 1, 2022

    365     $ 30.00                  

Granted

    97       30.63                  

Exercised

    (32 )     21.29             $ 350  

Forfeited

    (19 )     33.22                  

Outstanding at September 30, 2023

    411       30.68                  

Granted

    101       33.22                  

Exercised

    (38 )     30.79               194  

Forfeited

    (8 )     41.86                  

Outstanding at September 28, 2024

    466       31.03                  

Granted

    112       33.63                  

Exercised

    (54 )     26.95               568  

Outstanding at September 27, 2025

    524       32.01       6.89       3,549  
                                 

Vested and anticipated to vest in the future at September 27, 2025

    512       31.98       6.84       3,490  
                                 

Exercisable at September 27, 2025

    314       31.30       5.46       2,409  

 

Stock option exercises include “net exercises” for which the optionee received shares of common stock equal to the intrinsic value of the options (fair market value of common stock on the date of exercise less exercise price) reduced by any applicable withholding taxes.

 

Restricted stock units. Restricted stock units (“RSUs”) granted under our equity incentive plan are valued based upon the fair market value on the date of the grant and provide for a dividend equivalent payment which is included in compensation expense. The vesting period for RSUs is generally one year from the date of the grant for RSUs granted to directors and three years from the date of the grant for RSUs granted to employees. RSUs do not have voting rights. RSU grants and compensation expense are as follows:

 

    Year Ended  
   

September 27,

   

September 28,

   

September 30,

 

(In thousands)

 

2025

   

2024

   

2023

 

Restricted stock unit grants:

                       

Units

    68       52       57  

Market value

  $ 2,230     $ 1,769     $ 1,738  

Compensation expense

    2,070       1,730       1,392  

 

As of September 27, 2025, there was $1.3 million of unrecognized compensation cost related to unvested RSUs which is expected to be recognized over a weighted average period of 1.59 years.

 

The following table summarizes RSU activity:

 

           

Weighted

   

Aggregate

 
   

Restricted

   

Average

   

Intrinsic

 
   

Stock Units

   

Grant Date

   

Value

 

(Unit amounts in thousands)

 

Outstanding

   

Fair Value

   

(in thousands)

 

Balance, October 1, 2022

    120     $ 29.88          

Granted

    57       30.53          

Forfeited

    (10 )     30.36          

Vested

    (62 )     25.71     $ 1,911  

Balance, September 30, 2023

    105       35.07          

Granted

    52       33.56          

Vested

    (38 )     33.02       1,322  

Balance, September 28, 2024

    119       32.96          

Granted

    68       32.77          

Vested

    (40 )     35.05       1,323  

Balance, September 27, 2025

    147       32.31